Our findings, taken together with the established role of Fyn in modulating proinflammatory cytokines in immune cells highlights to us that FynT could be a potential therapeutic target for intervention of chronic inflammatory responses in neurodegenerative diseases including but not limited to AD. This evidence concerns the gene FYN and neurodegenerative disease.